Dr. Sawhney Published in Ophthalmology Times
- Posted on: Jan 22 2019
Despite significant progress in the fight against glaucoma, the human cost of this disease remains unacceptably high. According to the World Health Organization, glaucoma is the second-leading cause of blindness worldwide.
Dr. Sawhney explains why he considers netarsudil to be a valuable first- or second-line agent for therapeutic glaucoma treatment, as well as an effective addition to maximum medical therapy.
Georgia Eye Partners is a group practice of ophthalmologists and optometrists dedicated to providing our patients in Metro Atlanta and North Georgia with the highest quality medical and surgical specialty eye care. Learn more about our practice locations and book appointments online here.